Chinese Academy of Medical Sciences & Peking Union Medical College
(PDF) Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
Comparative pharmacokinetics and safety of imrecoxib | DDDT
IMRECOXIB | New Drug Approvals
Dose investigation of imrecoxib in patients with renal insufficiency based on modelling and simulation - ScienceDirect
Imrecoxib
Chinese Academy of Medical Sciences & Peking Union Medical College
PDF) A Randomized Comparison Study of Therapy Effects of Two Doses of Imrecoxib with Celecoxib on Axial Spondyloarthritis
IMRECOXIB | New Drug Approvals
Imrecoxib versus celecoxib as postoperative analgesia for patients receiving arthroscopic knee surgery: a randomized, controlled, non-inferiority study
IMRECOXIB | New Drug Approvals
IMRECOXIB | New Drug Approvals
Imrecoxib versus celecoxib as postoperative analgesia for patients receiving arthroscopic knee surgery: a randomized, controlled, non-inferiority study | SpringerLink
Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers | Scientific Reports
IMRECOXIB | New Drug Approvals
Comparative pharmacokinetics and safety of imrecoxib | DDDT
Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers | Scientific Reports
IMRECOXIB | New Drug Approvals
Comparative pharmacokinetics and safety of imrecoxib | DDDT
Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers | Scientific Reports
Comparative pharmacokinetics and safety of imrecoxib | DDDT
Dose investigation of imrecoxib in patients with renal insufficiency based on modelling and simulation - ScienceDirect
Comparative pharmacokinetics and safety of imrecoxib | DDDT
PDF) Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
Effect of Fluconazole on the Pharmacokinetic Properties of Imrecoxib, a Novel NSAID: A Single-center, Open-label, Self-controlled Study in Healthy Chinese Male Volunteers - ScienceDirect
Imrecoxib versus celecoxib as postoperative analgesia for patients receiving arthroscopic knee surgery: a randomized, controlled, non-inferiority study | SpringerLink
IMRECOXIB | New Drug Approvals
Comparative pharmacokinetics and safety of imrecoxib | DDDT
Comparative pharmacokinetics and safety of imrecoxib | DDDT
Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers | Scientific Reports
